Titan Pharmaceuticals, Inc. (TTNP)
NASDAQ: TTNP · Real-Time Price · USD
3.650
+0.040 (1.11%)
At close: Nov 20, 2024, 4:00 PM
3.600
-0.050 (-1.37%)
After-hours: Nov 20, 2024, 7:32 PM EST
Titan Pharmaceuticals Market Cap
Titan Pharmaceuticals has a market cap or net worth of $3.34 million as of November 21, 2024. Its market cap has decreased by -48.66% in one year.
Market Cap
3.34M
Enterprise Value
-754.05K
1-Year Change
-48.66%
Ranking
Category
Stock Price
$3.65
Market Cap Chart
Since December 1, 1998, Titan Pharmaceuticals's market cap has decreased from $41.00M to $3.34M, a decrease of -91.86%. That is a compound annual growth rate of -9.20%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Nov 19, 2024 | 3.40M | -45.16% |
Dec 29, 2023 | 6.20M | -46.09% |
Dec 30, 2022 | 11.50M | 13.86% |
Dec 31, 2021 | 10.10M | -53.24% |
Dec 31, 2020 | 21.60M | 100.00% |
Dec 31, 2019 | 10.80M | -37.93% |
Dec 31, 2018 | 17.40M | -38.08% |
Dec 29, 2017 | 28.10M | -66.86% |
Dec 30, 2016 | 84.80M | -4.83% |
Dec 31, 2015 | 89.10M | 76.09% |
Dec 31, 2014 | 50.60M | 0.60% |
Dec 31, 2013 | 50.30M | -39.18% |
Dec 31, 2012 | 82.70M | 22.16% |
Dec 30, 2011 | 67.70M | -3.97% |
Dec 31, 2010 | 70.50M | -47.66% |
Dec 31, 2009 | 134.70M | 11,125.00% |
Dec 31, 2008 | 1.20M | -98.41% |
Dec 31, 2007 | 75.60M | -41.49% |
Dec 29, 2006 | 129.20M | 177.85% |
Dec 30, 2005 | 46.50M | -55.29% |
Dec 31, 2004 | 104.00M | 23.37% |
Dec 31, 2003 | 84.30M | 113.42% |
Dec 31, 2002 | 39.50M | -85.44% |
Dec 31, 2001 | 271.20M | -70.48% |
Dec 29, 2000 | 918.70M | 209.74% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
NovaBay Pharmaceuticals | 3.46M |
Alaunos Therapeutics | 3.41M |
TNF Pharmaceuticals | 3.39M |
Oncternal Therapeutics | 3.37M |
Lixte Biotechnology Holdings | 3.35M |
Palisade Bio | 3.24M |
Quoin Pharmaceuticals | 3.16M |
Enveric Biosciences | 3.12M |